Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Debt / DBCV 1.375% 6/0
-
Market price (% of par)
-
135.31%
-
Total 13F principal
-
$45,947,000
-
Principal change
-
-$185,817,000
-
Total reported market value
-
$62,626,000
-
Number of holders
-
12
-
Value change
-
-$242,243,265
-
Number of buys
-
3
-
Number of sells
-
18
Institutional Holders of MEDICINES CO - DBCV 1.375% 6/0 as of Q2 2016
As of 30 Jun 2016,
MEDICINES CO - DBCV 1.375% 6/0 was held by
12 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$45,947,000
in principal (par value) of the bond.
The largest 10 bondholders included
Allianz Asset Management AG, CITADEL ADVISORS LLC, Polygon Management Ltd., MACKAY SHIELDS LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, EQUITEC SPECIALISTS, LLC, SSI INVESTMENT MANAGEMENT INC, PROSPECTOR PARTNERS LLC, WELLINGTON MANAGEMENT GROUP LLP, and ADVENT CAPITAL MANAGEMENT /DE/.
This page lists
12
institutional bondholders reporting positions
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.